Cystatin C prevents tissue injury after lung transplantation
Life Science Alliance · 2026
DOI: 10.26508/lsa.202503312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Henu Kumar Verma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (…. Hauptthemen laut MEDLINE: Cystatin C, Lung Transplantation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Lungenforschung.
Abstract (Originalsprache)
Lung transplantation (LTx) offers life-saving therapy for end-stage lung disease, yet primary graft dysfunction (PGD) and bronchiolitis obliterans syndrome remain major complications, which limit long-term outcomes. The risk of PGD increases with prolonged storage and reperfusion injury. This study investigated the protective effects of cystatin C (CysC), a cysteine protease inhibitor, against PGD, through neutralization of cathepsin B activity. LTx recipients exhibited reduced levels of CysC and greater lung damage reflected by increased γ-H2AX and ACSL4 expression, correlating with poorer outcome. Using an orthotopic LTx model, we engineered CysC-Alb, an albumin-fused, cell-permeable CysC derivative for enhanced lung preservation. Adding CysC-Alb to preservation solutions during cold storage and ex vivo lung perfusion improved oxygenation, reduced DNA damage, and minimized cell death, particularly in alveolar type 2 cells. In murine grafts, CysC-Alb decreased γ-H2AX and ACSL4 expression, markers of DNA damage and ferroptosis, respectively. These findings highlight CysC-Alb as an effective additive to mitigate early pulmonary dysfunction after LTx and improve lung graft viability and transplantation outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
- Inserm, Institut des Maladies Métaboliques et Cardiovasculaires, Universite de Toulouse, Toulouse, France.
- Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
- Department of Internal Medicine V, Ludwig-Maximilians University (LMU) Munich, CPC-M, Member of the German Center for Lung Research (DZL), Munich, Germany.
- Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), Excellence Cluster Cardiopulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Justus-Liebig Univers…
- Division of Respiratory Medicine, Department of Internal Medicine, Lung Research Cluster, Medical University of Graz, Graz, Austria.
ORCID-Profile: Henu Kumar Verma, Otmar Schmid, Nikolaus Kneidinger, Dieter E Jenne, Ali Önder Yildirim
Förderung
- Deutsches Zentrum für Lungenforschung
Zitieren
APA
Verma, H. K., Morrone, C., Rehm, S. R., Jeridi, A., Smirnova, N. F., Doryab, A., Weiß, S. A., Dashkevich, A., Schmid, O., Mümmler, C., Gerckens, M., Conlon, T. M., Hecker, M., Kneidinger, N., Jenne, D. E., & Yildirim, A. Ö. (2026). Cystatin C prevents tissue injury after lung transplantation. Life Science Alliance. https://doi.org/10.26508/lsa.202503312
Vancouver
Verma HK, Morrone C, Rehm SR, Jeridi A, Smirnova NF, Doryab A, et al. Cystatin C prevents tissue injury after lung transplantation. Life Science Alliance. 2026. doi:10.26508/lsa.202503312
BibTeX
@article{Verma2026,
author = {Verma, Henu Kumar and Morrone, Carmela and Rehm, Salome Rt and Jeridi, Aicha and Smirnova, Natalia F and Doryab, Ali and Weiß, Stefanie Ai and Dashkevich, Alexey and Schmid, Otmar and Mümmler, Carlo and Gerckens, Michael and Conlon, Thomas M and Hecker, Matthias and Kneidinger, Nikolaus and Jenne, Dieter E and Yildirim, Ali Önder},
title = {Cystatin C prevents tissue injury after lung transplantation},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202503312}
}
EUVIMED